Status:
COMPLETED
Proton Therapy for Early Stage Breast Cancer
Lead Sponsor:
Loma Linda University
Conditions:
Early-Stage Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine if partial breast proton therapy is effective treatment for early stage breast cancer following lumpectomy.
Detailed Description
Radiation therapy is considered standard treatment for most women with early stage breast cancer following lumpectomy. Post-lumpectomy radiotherapy is a proven treatment that reduces cancer recurrence...
Eligibility Criteria
Inclusion
- Invasive ductal, medullary, papillary, colloid or tubular histologies
- Stages T1 or T2 (tumors \< or = 3 cm) from lumpectomy specimen.
- No more then 3 positive nodes on axillary dissection or negative sentinel node.
- Negative surgical margins (\>2mm)
Exclusion
- Invasive lobular histology
- Previous chemotherapy for breast cancer
- Extensive intraductal component
- Collagen vascular disease
- Prior malignancy unless disease-free for 5 years
- Patients who are pregnant or lactating
Key Trial Info
Start Date :
February 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 12 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00614172
Start Date
February 1 2004
End Date
May 12 2020
Last Update
September 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Loma Linda University Medical Center / James M. Slater MD Proton Treatment Center / Department of Radiation Medicine / 11234 Anderson St.
Loma Linda, California, United States, 92354